Profil
Marc Buyse is the founder of One2treat SA, founded in 2023.
Dr. Buyse is the founder of International Drug Development Institute SA, founded in 1988, holding the title of Chairman & Chief Scientific Officer.
Dr. Buyse was the founder of CluePoints SA, founded in 2012, having held the title of Chief Scientific Officer.
Dr. Buyse is currently the Managing Director & Director at Clinimetrics SA since 2007.
Postes actifs de Marc Buyse
| Sociétés | Poste | Début |
|---|---|---|
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services Provides biostatistics and e-Clinical solutions for phase I-IV clinical trials | Fondateur | 01/01/1991 |
Clinimetrics SA
Clinimetrics SA Miscellaneous Commercial ServicesCommercial Services Provides market research services | Directeur Général | 23/06/2007 |
Anciens postes connus de Marc Buyse
| Sociétés | Poste | Fin |
|---|---|---|
CluePoints SA
CluePoints SA Packaged SoftwareTechnology Services Develops AI-powered and machine learning software solutions to clinical research | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services Provides biostatistics and e-Clinical solutions for phase I-IV clinical trials | Commercial Services |
CluePoints SA
CluePoints SA Packaged SoftwareTechnology Services Develops AI-powered and machine learning software solutions to clinical research | Technology Services |
Clinimetrics SA
Clinimetrics SA Miscellaneous Commercial ServicesCommercial Services Provides market research services | Commercial Services |
















